Table 3 Target population and discount
From: Benefit assessment in Germany: implications for price discounts
Overall | |||||
Size of target population | n | Mean | Min | Max | SD |
0–< 1000 | 34 | 20.84 | 1.00 | 53.71 | 12.15 |
1000–< 2500 | 38 | 21.28 | 0.00 | 42.54 | 11.53 |
2500–< 7500 | 31 | 19.79 | 4.74 | 39.44 | 9.00 |
7500–< 25000 | 32 | 21.61 | 2.01 | 46.44 | 11.43 |
25000–< 150000 | 34 | 23.88 | 3.16 | 67.30 | 15.12 |
150000+ | 24 | 25.18 | 2.01 | 78.02 | 19.50 |
Orphan drugs | |||||
Size of target population | n | Mean | Min | Max | SD |
0–< 300 | 10 | 13.70 | 1.00 | 24.50 | 8.15 |
300–< 1500 | 10 | 20.66 | 9.00 | 29.78 | 6.52 |
1500+ | 9 | 20.81 | 10.96 | 25.54 | 4.66 |